Chair: Joanne Bowen
The relevance or not of biomarkers to clinical outcomes; whose agenda? (#21)
4:00 PM
Hypertension impairs cognitive function and exacerbates amyloid-β pathology in Alzheimer’s transgenic APP/PS1 mouse model (#22)
4:35 PM
Assessing skeletal muscle bioenergetics in situ: characterising metabolic perturbations in a mouse model of motor neuron disease (#23)
4:47 PM
Real time assessment of altered signalling pathways in the pathobiology of Chronic Obstructive Pulmonary Disease (#24)
4:59 PM
Botulinum toxin for Foot Dystonia in Patients with Parkinson's Disease having Deep Brain Stimulation: A Case series and a Pilot study. (#25)
5:11 PM
Acute malaria reveals differential roles for programmed death-1 (PD-1) and its ligands in T cell-mediated protection (#26)
5:23 PM